SK pharmteco
Brian Fairley is a Vice President of Business Development at SK pharmteco since July 2020. Prior to this, Brian was a Director of Business Development and Marketing at SK biotek from July 2018 to July 2020. With a background in chemistry, Brian has held various leadership roles in sales, marketing, and commercial API development at Johnson Matthey Pharma Services. Brian also has experience as a Product Manager and Development Chemist at Rhodia Pharma Solutions and Rhodia Chirex. Brian completed their Doctor of Philosophy (PhD) and Bachelor of Science (BSc) degrees in Chemistry from Heriot-Watt University.
This person is not in any offices
SK pharmteco
Headquartered in Rancho Cordova, California, SK pharmteco is a global contract development and manufacturing organization specializing in the production of active pharmaceutical ingredients (APIs), advanced intermediates, and cell and gene therapy for the pharmaceutical industry. Built on 80 years of experience, our global operations have the capability and capacity to support client needs from development through commercial production. SK pharmteco is owned by SK Inc., the strategic investment arm of South Korea’s SK Group.